Flagship Wealth Advisors’s AbbVie ABBV Stock Holding History

Flagship Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Buy	5,034 +2,190	+77%	+$471K	0.28%	52
2026 Q1	$528K	Sell	2,844 -2,153	-43%	-$478K	0.23%	59
2025 Q4	$1.14M	Buy	4,997 +1,538	+44%	+$350K	0.33%	48
2025 Q3	$801K	Sell	3,459 -1,422	-29%	-$290K	0.26%	57
2025 Q2	$906K	Buy	4,881 +113	+2%	+$21K	0.34%	50
2025 Q1	$999K	Sell	4,768 -19	-0.4%	-$3.69K	0.42%	43
2024 Q4	$851K	Buy	+4,787	New	+$880K	0.5%	38

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Flagship Wealth Advisors's ABBV Position: Q2 2026 in Review

Flagship Wealth Advisors increased its AbbVie (ABBV) stake by 77% in Q2 2026, buying an estimated $471K and bringing the position to 5,034 shares worth $1.27M. The position accounts for 0.28% of the portfolio, ranked #52.

Flagship Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Flagship Wealth Advisors held 5,034 shares of AbbVie worth $1.27M as of Q2 2026.
Flagship Wealth Advisors bought 2,190 AbbVie shares in Q2 2026, an estimated $471K.
AbbVie made up 0.28% of Flagship Wealth Advisors's portfolio in Q2 2026, its #52 holding.
Flagship Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Flagship Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.